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DESPONDENCY has been expressed inseveral quarters that improved treatment
and apparently successful efforts to persuade those afflicted with cancer to present
themselves early for diagnosis -and treatment have not been reflected in a fall in
mortality rates. Much of this disappointment seems due to the feeling that the
only successful outcome oftreatment is that which results in an absolute cure and
other possibilities appear largely to have been neglected. Although the complete
extirpation of the cancer focus so that the patient is subsequently subject to
normal mortality risk only is the ideal to be aimed at, yet treatment short ofthis
may still confer such benefit that it may justly be described as successful. Even
though the word cure be inadmissible the disease may be arrested for a longer or
a shorter time and the expectation of life considerably increased; at the worst
treatment may make existence more comfortable without affecting the ultimate
prognosis. Mortality rates can only be affected by results under the first two of
these heads, and though it is obvious that the result of cure should be reflected
in an early fall in mortality, the effect ofprolongation oflife is more complicated.
Without attempting to differentiate between the effects of a complete cure or a
prolongation of life this note will be concerned with the effect upon mortality
rates of a hypothetical increase in the mean duration of survival of some typical
cancers. It will be assumed that the average expectation of life of all cancer
cases has been increased by two and a half years and the effect of this upon the
mortality rates at the following sites will be considered; the results differ for
cancer ofdifferent sites and depend upon variations in the curve ofmortality with
age. Five sites, each showing a different type of age mortality curve, have been
selected (Fig. 1). First, cancer ofthe stomach in males, for which the cancer mor-
tality curve follows the classical type for non-genital cancers in that it starts at a
low rate in early adult life and steadily and rapidly increases with increasing age.
Second, cancer ofthelunginmales, forwhichthe curvefollowsthe classicalpattern
until about the age of 55 when the upward slope decreases until there is a final
fall. Third, cancer of the prostate, for which mortality at early ages is small,
but after 50 the death-rate increases with extreme rapidity until old age. Fourth,
cancer of the uterus, for which the rate increases rapidly in early adult life, less
during middle age and changes little after 60 years of age. Finally cancer of the
female breast, where the rate increases with each increase in age but more rapidly
below the age of 45. The mortality records of 1952 have been used in five-year
age-groups from 30-74 and for all ages over 75. To estimate the effect of an all-
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round increase in expectation oflife oftwo and a half years, one halfofthe deaths
recorded in each age-group for each type of cancer have been transferred to the
age-group above and from these two sets of figures mortality rates per million
living have been calculated, the rates resulting from the hypothetical extension
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FIG. 1.-Age specific mortality rates per million living shown on a logarithmic curve for cancer
of: Males-lung, prostate and stomach; Females-breast and uterus.
Recorded rates in England and Wales 1952.
- - - - - Calculated rates, assuming 2'5 years extension of life in each individual case; the
histogram at the foot ofeach curve shows the percentage change in the rate at each age group.
oflife being expressed as a percentage of the observed rates (Table I). It is seen
that at the earliest ages the increased expectation of life lowers the mortality
rates, while above 75 years the hypothetical rate considerably exceeds the obser-
ved; between these extremes the relation ofthe two rates varies with the type of
age mortality rate curve. The effect ofthis change in expectation oflife at differ-
ent ages is shown graphically for each site in the diagram.
1000
100
40D
o ._
3-
a)
.o 10
.a
c-
L.
4)
-0 1'. iooo
*r_
0 $)
,& 100
10
+50%
U
50%
I 0
i
2
-
-
-
-3NT OF CANCER AND M
_ r . oXa>sc
o V coo o oo o oo
-~ ~ ~
-
-I
q ~~~~~~~~e
o . . . . . . . . .
WI~~~~~~~a
· . C o . . . O . 0 .
Co1- CO COO 0 ; ^ > t u: b ao o cq e
M~~~~~0 M t_It
_s~ ~ ~~~~c
L -
E.
. . . . . . . .
0 100co Co CCO -OD
_ _m CD = ao D m eC C
01C0 0 -o CO t- 1 co
01Co t- o0
rq _z cs4 cosK r-
- ~~ ~ ~ ~~~~~~-
!t . .c 0ore1
O¢ tom>010 CO COO
O 0t O ~4tJ- t CO CO CO 1
L' Co Co r to~ COO 0o0110
R~~ ~~~ - --ee |eU
10p C 0COCO0
01 C .*.*- - O ~ OC
- 4 0 Co 1 1Q 0 C
t' . - E' OsO CO C
@~~~~ ^4COC CO
_ 1 * 0 Co 0 C o00- CO
_ _ _1 'V>sec rr^ 01 CO
CO CO t O 101 Co CoEs
IORTALITY RATES
1 ,C)
I bco
14
4 W
h4 Coo
CS ,cI *f
* t j
C.)
TREATME 3A. McKENZIE
Considering first the more general case of cancer of the stomach in males
we see.that between 30 and 50 years of age the hypothetical death rate is about
30 per cent below the observed, between 55 years and 70 years the difference is
reduced to about 10per cent, while fortheage-group 70-74therates are practically
the same and for the last group, those over 75, the hypothetical rate is naturally
very much higher and is 36 per cent above the observed mortality. In cancer
of the prostate, the new rate varies within 70 and 80 per cent of the observed
until the age of 65 years, when it rapidly rises to 125 per cent over 75 years. In
contradistinction to this are cancer of the lung in males and cancer of the uterus,
for which sites the curves show mortality to increase until the seventh decade
of life and thereafter to fall or remain stationary. In both cancers the difference
between therecorded mortalityrates andthe rates calculatedfrom ourassumptions
progressively diminishes between 30 and 60 years ofage. The assumed extension
oflife actually increases the mortality rates in the three age-groups over 65 years,
more strikingly in the case of the lung, where the real rates over 65 fall, than in
the case ofthe uterus, where they remain steady. The mortality curve of cancer
of the female breast rises steeply between 30 and 39 years of age and continues
from 45 to 69 years at a much reduced gradient, when it again ascends. Between
30-34years ofagethe supposedincrease oflifereduces the mortalityrate bynearly
40 per cent, but before 50 is reached the difference has fallen to 6 per cent and
thereafter until 75 the rates are scarcely affected.
The addition of two and a half years of life to every person who dies from
cancer would prove no mean medical feat and would be accompanied by a con-
siderable change for the better in the crude survival rate. In Table II are shown
first the five-year crude survival rates for the sites discussed above, for all cases,
treated and untreated, which were registered under the Cancer Registration
Scheme in 1945 and 1946; and second, the calculated rate assuming an extension
of life of two and a half years for each cancer patient. (The corrected rates,
according to the method of Berkson, show similar relationships.)
TABLE II.
1945-6 Calculated rate
Cancer Registrations assuming 2'5 years
5-year survival rate. extension of life. Increase.
% % %
Stomach, male . . 4-6 . 68 . 48
Lung, male . . . 1.5 . 3-0 . 100
Prostate . . . 150 . 310 48
Uterus (cervix only) . 32-0 . 440 37
Breast, female . . 31-0 . 49-0 . 58
Recent mortality records show that at several sites the distribution of cancer
deaths among the different age groups is changing, often without commensurate
alterations in the overall mortality rate. At only a few sites has the mortality
rate over 75 years declined, and these sites contribute little to the total cancer
picture; lips, liver and skin in both sexes, and tongue in males, are the most
noteworthy; at nearly all other sites the mortality rate at this older age has
either risen or remained steady during the last twenty years. At the following
important sites the rates below 75 years are falling, while those above have risen
or show no change. Males: oesophagus, intestine, rectum, mouth, larynx and
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prostate. Females: mouth, larynx, stomach, intestine, rectum and uterus.
Both sexes: "all other sites," excluding cancer ofthe lung. Cancer ofthe male
larynx, the age specific rates of which are shown in Fig. 2, illustrates well this
pattern. Between 1936 and 1952 the rates between 45 and 74 years of age have
fallen by approximately 30 per cent. Some beneficial change must be taking
place, though its nature is obscure and even its existence not apparent unless a
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FIG. 2.-Cancer of male larynx, England and Wales, 1936-1952. Mortality rates per
million living shown on a logarithmic scale for 5-year age-groups.
detailed analysis of the records is undertaken. The effect could be produced by
any one of the following mechanisms or by a combination of all three:
(a) A shift in the mean age ofincidence to older groups, caused perhaps
by a waning effect of the hypothetical cancer-producing factor, or by a
change in habits at younger ages which postpones full contact with the
factor until later life.
(b) An increased expectation of life for all cancer patients as outlined
above, due either to improved or earlier treatment, to increased individual
resistance, or a decline in the "malignancy " of the cancer.
(c) A greater proportion ofcomplete cures affecting mainly the younger
ages and removing them from the cancer mortality tables.
To estimate the relative importance of any single mechanism it would be
necessary to integrate incidence and survival rates with mortality experience,
and this will not be possible until cancer registration covers a broader field than
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at present, when we should be in a position to realise not only that something is
happening but also determine what is happening.
This note is restricted solely to the effects ofan extension oflife upon mortality
rates, the complete analysis should take account ofcures and consequent reduction
in numbers of persons dying from cancer as well as possible changes in total or
average age incidence. Sufficient has, however, been said to show that any
deduction drawn from changes in mortality rates must be related to the trends
of the age mortality rate curve and that the absence of any general fall in over-
all rates is not incompatible with considerable improvements in prognosis.
SUMMARY.
The effect on cancer mortality rates of an increase in the duration of survival
from cancer at certain typical sites is discussed. The resulting changes in the
rates are not constant and vary with the form ofthe mortality curve.